Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Caliber Therapeutics
Caliber Therapeutics develops stent-free drug delivery products for atherosclerotic diseases.
Sector
Subsector
Location
total rounds
total raised
Mati Therapeutics
Mati Therapeutics is a biotechnology company that develops drug delivery tools for the treatment of age-related macular degeneration.
Sector
Subsector
Keywords
Location
total rounds
total raised
Everads Therapy
Everads Therapy is a company that develops a drug and cell delivery system for treating retinal diseases.
Sector
Subsector
Location
OptiNose
OptiNose develops nasal drug delivery technologies and combined drug and device therapies.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds4
Number of Funding Rounds
Money Raised
Their latest funding was raised on 30.11.2022. Their latest investor Visionary Venture Fund. Their latest round Series A
Visionary Venture Fund
Visionary is a venture capital firm that invests in emerging ophthalmology companies in medical devices and pharmaceuticals.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Visionary Venture Fund
Visionary is a venture capital firm that invests in emerging ophthalmology companies in medical devices and pharmaceuticals.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
ExSight Ventures
ExSight Ventures is a venture capital firm investing in ophthalmic solutions.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors9
Number of lead investors
Number of investors
Visionary Venture Fund
Visionary is a venture capital firm that invests in emerging ophthalmology companies in medical devices and pharmaceuticals.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Robert Avery
Robert Avery is a MD, of Visionary Ventures.
Garrett Hamontree
current job
Techstart Ventures
Techstart Ventures is a leading seed capital investor in Scotland and Northern Ireland.
Sector
Subsector
Location
count Of Investments
count Of Exists
ExSight Ventures
ExSight Ventures is a venture capital firm investing in ophthalmic solutions.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Michael Nissen
Michael Nissen is a partner at ExSight. He is an experienced clinician with a particular interest in the surgical instruction of retina fellows in the US and abroad as well as a faculty member at Weill-Cornell University Medical Center since 1998. Michael Nissen is the founder and director of the Insight Foundation. He is a member of the American Academy of Ophthalmology, the American Society of Retinal Specialists, and the New York Ophthalmological Society. Michael Nissen received his BA from Middlebury college then attended the premedical program at Columbia University and then The Albany Medical College. He served his ophthalmology residency at Lenox Hill Hospital in New York City and fellowships in Ophthalmic Pathology at the New York Eye And Ear Infirmary, Medical Retina at New York University Medical Center, and Surgical Retina at Vitreous-Retina Consultants in New York.
current job
Firas Rahhal
Firas Rahhal is a partner at ExSight, a senior partner at Retina-Vitreous Associates Medical Group in Los Angeles, and is Associate Clinical Professor of Ophthalmology at the UCLA School of Medicine - Jules Stein Eye Institute. He has published dozens of scientific papers in respected peer-reviewed journals, is a frequent presenter at major international scientific meetings, and has been an investigator in over 100 clinical trials, including trials leading to novel therapies for vitreoretinal diseases. Firas Rahhal has been consistently named “Top Doctor” by his physician peers in the Los Angeles Magazine annual review. Firas Rahhal received a Bachelor’s degree in Biochemistry from the University of Pennsylvania, his MD from the University of Connecticut, completed an Ophthalmology Residency at Cornell University Medical Center, and, subsequently, a two-year Fellowship in Vitreoretinal Surgery and Uveitis at the University of California, San Diego. Firas Rahhal served at Cornell University as Assistant Professor of Ophthalmology and Director of the Retina Service for five years.
current job
James Murray
James is a co-founder and partner at ExSight Ventures where he has helped lead the firm’s investments in nine transformative ophthalmic companies. In addition to serving on the ExSight investment committee he helms the firm’s operations. His duties include sourcing and evaluating early-stage companies, assisting current and prospective portfolio companies, and is responsible for the firm’s operational functions. He serves on the board of Re-Vana Therapeutics, Ltd, a Northern Ireland ocular pharmaceuticals and drug delivery company, Usher III Initiative, a nonprofit dedicated to finding treatments for individuals with Usher III, and Nectar Services, an unaffiliated New York UCaaS company. James is a board observer at 2C Tech, a California company pioneering nanoparticle technology to treat blinding ophthalmic disease. Prior to co-founding ExSight Ventures, James held various positions at a New York City asset management company, eventually serving as General Counsel and Head of Strategic Initiatives. James is admitted to practice law in the State of New York. He is a member of the Association of the Bar of the City of New York where he serves as Chair of the Emerging Companies and Venture Capital Committee. James received his B.A. from Canisius College and his J.D. from Brooklyn Law School.
current job
People
Founders2
Raghu Raj Singh Thakur
Raghu Raj Singh Thakur is the Founder & CTO at Re-Vana Therapeutics.
current job
organization founded
Raghu Raj Singh Thakur
David Jones
David Jones is the Elected Fellow at Royal Statistical Society.
current job
organization founded
David Jones